Skip to main content
Toggle navigation
Search
Home
Full Schedule
Home
Full Schedule
All Days
Wed, Nov 1
Thu, Nov 2
Fri, Nov 3
On-Demand
Full Schedule
Type here to filter the list
Thursday, November 2, 2023
8:00 AM – 8:15 AM
ET
Welcome and Introduction
8:00 AM – 8:15 AM
ET
Welcome and Introduction
8:15 AM – 8:50 AM
ET
Session 8: Advanced Ovarian Cancer Therapies: PARP Inhibitors and Beyond
8:15 AM – 8:50 AM
ET
Session 8: Advanced Ovarian Cancer Therapies: PARP Inhibitors and Beyond
Presenter:
Debra Richardson, MD
– Stephenson Cancer Center, University of Oklahoma Health Sciences Center
8:50 AM – 9:00 AM
ET
Live Q&A
8:50 AM – 9:00 AM
ET
Live Q&A
Moderator:
Kathleen N. Moore, MD, MS
– Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Presenter:
Debra Richardson, MD
– Stephenson Cancer Center, University of Oklahoma Health Sciences Center
9:00 AM – 9:15 AM
ET
Break
9:00 AM – 9:15 AM
ET
Break
9:15 AM – 9:50 AM
ET
Session 9: Relapsing Ovarian Cancer: Expert Advice for Selecting New and Emerging Targeted Therapeutics
9:15 AM – 9:50 AM
ET
Session 9: Relapsing Ovarian Cancer: Expert Advice for Selecting New and Emerging Targeted Therapeutics
Presenter:
Colleen McCormick, MD, MPH
– University of New Mexico Cancer Center
9:50 AM – 10:00 AM
ET
Live Q&A
9:50 AM – 10:00 AM
ET
Live Q&A
Moderator:
Kathleen N. Moore, MD, MS
– Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Presenter:
Colleen McCormick, MD, MPH
– University of New Mexico Cancer Center
10:00 AM – 10:15 AM
ET
Break
10:00 AM – 10:15 AM
ET
Break
10:15 AM – 11:15 AM
ET
Non-CME Innovation Theater
10:15 AM – 11:15 AM
ET
Non-CME Innovation Theater
11:15 AM – 11:30 AM
ET
Break
11:15 AM – 11:30 AM
ET
Break
11:30 AM – 12:05 PM
ET
Session 10: Food Insecurity in Oncology
11:30 AM – 12:05 PM
ET
Session 10: Food Insecurity in Oncology
Presenter:
Christina Washington, MD
– University of Oklahoma
12:05 PM – 12:15 PM
ET
Live Q&A
12:05 PM – 12:15 PM
ET
Live Q&A
Moderator:
Kathleen N. Moore, MD, MS
– Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Presenter:
Christina Washington, MD
– University of Oklahoma
12:15 PM – 12:30 PM
ET
Break
12:15 PM – 12:30 PM
ET
Break
12:30 PM – 1:05 PM
ET
Session 11: Updates from Recent Meetings
12:30 PM – 1:05 PM
ET
Session 11: Updates from Recent Meetings
Presenter:
Ramez Eskander, MD
– University of California, San Diego
1:05 PM – 1:15 PM
ET
Live Q&A
1:05 PM – 1:15 PM
ET
Live Q&A
Presenter:
Ramez Eskander, MD
– University of California, San Diego
1:15 PM – 1:30 PM
ET
Break
1:15 PM – 1:30 PM
ET
Break
1:30 PM – 2:30 PM
ET
Non-CME Innovation Theater
1:30 PM – 2:30 PM
ET
Non-CME Innovation Theater
2:30 PM – 2:45 PM
ET
Break
2:30 PM – 2:45 PM
ET
Break
2:45 PM – 3:20 PM
ET
Session 12: Collateral Damage: Side Effects of Breast Cancer Treatment
2:45 PM – 3:20 PM
ET
Session 12: Collateral Damage: Side Effects of Breast Cancer Treatment
Presenter:
Marissa Marti-Smith, MSN, APRN, AGNP-C, AOCNP
– Texas Oncology -Baylor Charles A. Sammons Cancer Center
3:20 PM – 3:30 PM
ET
Live Q&A
3:20 PM – 3:30 PM
ET
Live Q&A
Moderator:
Erika P. Hamilton, MD
– Sarah Cannon Research Institute (SCRI)
Presenter:
Marissa Marti-Smith, MSN, APRN, AGNP-C, AOCNP
– Texas Oncology -Baylor Charles A. Sammons Cancer Center
3:30 PM – 3:45 PM
ET
Break
3:30 PM – 3:45 PM
ET
Break
3:45 PM – 4:30 PM
ET
Session 13: Debate: Should We Quantify HER-2 Expression for Use of TDXd and Other ADCs?
3:45 PM – 4:00 PM
ET
Session 13: Debate: Should We Quantify HER-2 Expression for Use of TDXd and Other ADCs? - NO
Presenter:
Paolo Tarantino, MD
– Dana-Farber Cancer Institute, Harvard Medical School
4:00 PM – 4:15 PM
ET
Session 13: Debate: Should We Quantify HER-2 Expression for Use of TDXd and Other ADCs? - YES
Presenter:
Giuseppe Curigliano, Professor MD PhD
– European Insitute of Oncology, IRCCS and University of Milano
4:15 PM – 4:30 PM
ET
Live Panel Discussion
Moderator:
Erika P. Hamilton, MD
– Sarah Cannon Research Institute (SCRI)
Panelist:
Giuseppe Curigliano, Professor MD PhD
– European Insitute of Oncology, IRCCS and University of Milano
Panelist:
Paolo Tarantino, MD
– Dana-Farber Cancer Institute, Harvard Medical School
4:30 PM – 4:45 PM
ET
Break
4:30 PM – 4:45 PM
ET
Break
4:45 PM – 5:20 PM
ET
Session 14: CDK4/6 Inhibitors Results in Early and Metastatic Breast Cancer
4:45 PM – 5:20 PM
ET
Session 14: CDK4/6 Inhibitors Results in Early and Metastatic Breast Cancer
Presenter:
Komal Jhaveri, MD, FACP
– Memorial Sloan Kettering Cancer Center
5:20 PM – 5:30 PM
ET
Live Q&A
5:20 PM – 5:30 PM
ET
Live Q&A
Presenter:
Komal Jhaveri, MD, FACP
– Memorial Sloan Kettering Cancer Center
